Breaking News, Collaborations & Alliances

Sobi, Enable Partner on Subcutaneous Drug Delivery

Will develop and distribute Aspaveli in combination with enFuse in Sobi territories.

Author Image

By: Charlie Sternberg

Associate Editor

Sobi and Enable Injections Inc. have announced an international development and distribution agreement across Sobi territories for the enFuse Injector, for the subcutaneous delivery of Aspaveli (pegcetacoplan).   The enFuse Injector, to be produced by Enable and distributed by Sobi, is designed to streamline and improve patients’ self-administration experience with minimal disruption to their daily lives via the use of enFuse technology. This allows wearable, hidden needle drug delivery ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters